W. Anthony Vernon
Director, McCormick & Company.
Companies
- Nuvation Bio Inc.Board member Feb 12, 2021 to now1
- McCormick & CompanyBoard member May 25, 2017 to now2
- NovoCure LtdBoard member Oct 1, 2015 to now3
- Intersect ENTBoard member Apr 10, 2015 to Jun 8, 20204
- Sio Gene Therapies Inc.Board member Apr 11, 2017 to May 16, 20175
- MedivationBoard member Jul 18, 2006 to Sep 30, 20166
- Kraft Foods GroupBoard member Aug 17, 2012 to Mar 9, 20157
- Kraft Foods GroupChief executive officer Oct 4, 2012 to Oct 3, 20148
- Mondelez InternationalEVP & Pres, Kraft Foods NA Aug 18, 2010 to Aug 21, 20129
- Kraft Foods GroupPresident Aug 17, 2012 to Aug 17, 20127
- Mondelez InternationalPresident Aug 18, 2009 to Feb 25, 201010
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- NovoCure Ltd NVCR209,267 shares11$3.1M at $14.88Jun 3, 2026
McCormick & Company MKC14,048 shares12$644.7K at $45.90Feb 15, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 3, 2026Granted 11,610 shares of NovoCure Ltd11
- Jun 2, 2026Sold 2,945 shares at $15.77 of NovoCure Ltd13
- Apr 28, 2026Exercised options 21,500 shares at $11.39 of NovoCure Ltd14
- Feb 15, 2026Exercised options 2,222 shares of McCormick & Company12
- Jun 4, 2025Granted 11,215 shares of NovoCure Ltd15
- Jun 3, 2025Sold 999 shares at $17.35 of NovoCure Ltd16
- Mar 15, 2025Exercised options 1,344 shares of McCormick & Company17
- Jun 5, 2024Granted 4,053 shares of NovoCure Ltd18
- Jun 4, 2024Sold 964 shares at $23.89 of NovoCure Ltd18
- Mar 15, 2024Exercised options 1,255 shares of McCormick & Company19
- Jun 7, 2023Granted 3,853 shares of NovoCure Ltd20
- Mar 15, 2023Exercised options 1,044 shares of McCormick & Company21
- Mar 15, 2022Exercised options 1,139 shares of McCormick & Company22
- Mar 15, 2021Exercised options 1,468 shares of McCormick & Company23
- Mar 15, 2020Exercised options 689 shares of McCormick & Company24
- Mar 15, 2019Exercised options 962 shares of McCormick & Company25
- Mar 15, 2018Exercised options 990 shares of McCormick & Company26
- May 23, 2017Granted 147 shares at $102.53 of McCormick & Company27
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNuvation Bio Inc., Board member
- 2SEC EDGARMcCormick & Company, Board member
- 3SEC EDGARNovoCure Ltd, Board member
- 4SEC EDGARIntersect ENT, Board member
- 5
- 6SEC EDGARMedivation, Board member
- 7SEC EDGARKraft Foods Group, Board member
- 8
- 9
- 10SEC EDGARMondelez International, President
- 11
- 12
- 13SEC EDGARForm 4 filed Jun 3, 2026
- 14SEC EDGARForm 4 filed Apr 28, 2026
- 15SEC EDGARForm 4 filed Jun 6, 2025
- 16SEC EDGARForm 4 filed Jun 4, 2025
- 17SEC EDGARForm 4 filed Mar 18, 2025
- 18SEC EDGARForm 4 filed Jun 6, 2024
- 19SEC EDGARForm 4 filed Mar 19, 2024
- 20SEC EDGARForm 4 filed Jun 9, 2023
- 21SEC EDGARForm 4 filed Mar 16, 2023
- 22SEC EDGARForm 4 filed Mar 17, 2022
- 23SEC EDGARForm 4 filed Mar 16, 2021
- 24SEC EDGARForm 4 filed Mar 17, 2020
- 25SEC EDGARForm 4 filed Mar 19, 2019
- 26SEC EDGARForm 4 filed Mar 19, 2018
- 27SEC EDGARForm 4 filed May 25, 2017